help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Gehani, F.
Right arrow Articles by Huhtaniemi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Gehani, F.
Right arrow Articles by Huhtaniemi, I.
Endocrinology Vol. 139, No. 4 1474-1480
Copyright © 1998 by The Endocrine Society


ARTICLES

Vasoactive Intestinal Peptide Is an Important Endocrine Regulatory Factor of Fetal Rat Testicular Steroidogenesis1

Faraj El-Gehani, Manuel Tena-Sempere and Ilpo Huhtaniemi

Department of Physiology, University of Turku, Turku, Finland

Address all correspondence and requests for reprints to: Prof. Ilpo Huhtaniemi, Department of Physiology, University of Turku, Kiinamyllynkatu 10, 20520 Turku, Finland. E-mail: ilpo.huhtaniemi{at}utu.fi

This study elaborates our recent preliminary finding that vasoactive intestinal peptide (VIP) has a specific stimulatory effect on fetal rat Leydig cells. We examined the dose-response relationship for the effect of VIP on cAMP and testosterone production by dispersed fetal Leydig cells isolated from rat testes on embryonic day (E) 18.5. Further, we used RT-PCR to examine the expression of the VIP gene in fetal brain and testes and that of the VIP receptor genes in fetal testes and used RIA to measure VIP in testes and plasma during the fetal period. VIP stimulated fetal testicular cAMP production at a dose of 10-9 mol/liter, whereas a dose as low as 10-12 mol/liter stimulated testosterone production. This suggests that VIP at low doses may stimulate testosterone production using second messenger pathways other than cAMP. RT-PCR analysis could not reveal either VIP messenger RNA (mRNA) in fetal tissues or VIP1 receptor mRNA in the fetal or newborn testes, whereas VIP2 receptor mRNA was detected in fetal testes as early as E15.5. Northern hybridization analysis showed that the level of expression of VIP2 receptor mRNA is very low in fetal and neonatal testes and increases with age. The testicular VIP content was unmeasurable by our RIA method (i.e. <1 fmol/testis), whereas the circulating level of VIP was 82.9 ± 1.1 pmol/liter on E17.5 and decreased with advancing fetal age.

In conclusion, our results suggest that VIP from an extratesticular source, possibly from the maternal compartment, may regulate fetal testicular steroidogenesis through type 2 receptors as early as E15.5. These findings may be of physiological significance, because the onset of fetal testicular steroidogenesis occurs at an age (E15.5–19.5) before the onset of pituitary LH secretion.




This article has been cited by other articles:


Home page
ReproductionHome page
C A Wilson and D C Davies
The control of sexual differentiation of the reproductive system and brain
Reproduction, February 1, 2007; 133(2): 331 - 359.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Pakarainen, F.-P. Zhang, S. Makela, M. Poutanen, and I. Huhtaniemi
Testosterone Replacement Therapy Induces Spermatogenesis and Partially Restores Fertility in Luteinizing Hormone Receptor Knockout Mice
Endocrinology, February 1, 2005; 146(2): 596 - 606.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Pakarinen, S. Kimura, F. El-Gehani, L. J. Pelliniemi, and I. Huhtaniemi
Pituitary Hormones Are Not Required for Sexual Differentiation of Male Mice: Phenotype of the T/ebp/Nkx2.1 Null Mutant Mice
Endocrinology, November 1, 2002; 143(11): 4477 - 4482.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. G. Parks, J. S. Ostby, C. R. Lambright, B. D. Abbott, G. R. Klinefelter, N. J. Barlow, and L. E. Gray Jr.
The Plasticizer Diethylhexyl Phthalate Induces Malformations by Decreasing Fetal Testosterone Synthesis during Sexual Differentiation in the Male Rat
Toxicol. Sci., December 1, 2000; 58(2): 339 - 349.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. El-Gehani, M. Tena-Sempere, and I. Huhtaniemi
Evidence That Pituitary Adenylate Cyclase-Activating Polypeptide Is a Potent Regulator of Fetal Rat Testicular Steroidogenesis
Biol Reprod, November 1, 2000; 63(5): 1482 - 1489.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
S. Gräs, C. Hedetoft, S. H. Pedersen, and J. Fahrenkrug
Pituitary Adenylate Cyclase-Activating Peptide Stimulates Acute Progesterone Production in Rat Granulosa/Lutein Cells via Two Receptor Subtypes
Biol Reprod, July 1, 2000; 63(1): 206 - 212.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
D. Vaudry, B. J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: From Structure to Functions
Pharmacol. Rev., June 1, 2000; 52(2): 269 - 324.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. R. Manna, M. Tena-Sempere, and I. T. Huhtaniemi
Molecular Mechanisms of Thyroid Hormone-stimulated Steroidogenesis in Mouse Leydig Tumor Cells. INVOLVEMENT OF THE STEROIDOGENIC ACUTE REGULATORY () PROTEIN
J. Biol. Chem., February 26, 1999; 274(9): 5909 - 5918.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society